Dynamic gene expression analysis reveals distinct severity phases of immune and cellular dysregulation in COVID-19
A. An, A. Baghela, P. Zhang, T. M. Blimkie, J. Gauthier, D. E. Kaufmann, E. Acton, A. H. Lee, R. C. Levesque, R. E. W. Hancock
This study analyzes longitudinal gene expression in COVID-19 patients to identify distinct disease phases and associated therapeutic targets.
bioRxiv · Nov 4, 2023 · PreprintImmunology